Physician
Infectious Disease
Fehmida I. Visnegarwala, MB
|
|
Give Review
Fehmida Visnegarwala works in the field of Infectious Disease. She graduated from Baylor College of Medicine. Fehmida Visnegarwala is also a published doctor. She has 33 publication published. The most recent publication is: Gynecomastia associated with indinavir therapy.
Publications
- Predictors of HIV positivity among pregnant women presenting for obstetric care in South India - a case-control study.
- Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study.
- The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters.
- Continuous antiretroviral therapy decreases bone mineral density.
- Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.
- Effects of HIV infection on body composition changes among men of different racial/ethnic origins.
- Visceral and subcutaneous adiposity measurements in adults: influence of measurement site.
- Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or ...
- Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent ...
- Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons.
- Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy.
- Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure.
- Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co...
- The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy.
- Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort.
- Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.
- Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine.
- Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
- Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active?
- Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
- Changes in metabolic profile among antiretroviral-naive patients initiating protease inhibitor versus non-protease inhibitor containing HAART regimens.
- Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?
- Use of bDNA testing in the immunologically nonresponding patient who has a low or undetectable viral load by RT-PCR testing.
- Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.
- Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic.
- Metabolic basis of HIV-lipodystrophy syndrome.
- Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.
- HIV-1 protease inhibitors may interfere with the ubiquitous intracellular proteases.
- Gynecomastia associated with indinavir therapy.
- Ventilator-associated pneumonia.
- Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors.
- Severe diabetes associated with protease inhibitor therapy.
Schools
Madras Medical College
Saint Francis Hospital
Baylor
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Baylor College of Medicine -
Stanley Medical College SMC